15,000 second chances: Bone Marrow Transplant program celebrates new milestone

April 24, 2019 | Michael Easterling and Samantha Bonar

City of Hope’s bone marrow transplant program recently performed the procedure on its 15,000th patient, a remarkable milestone considering that the initiative started with just two physicians, three beds and guarded expectations in 1976.

Continue Reading

International diabetes experts converge for Levine-Riggs symposium

April 23, 2019 | Michael Easterling

More than 250 physicians and scientists from around the world attended the 2019 City of Hope Levine-Riggs Diabetes Research Symposium, held April 10 to 13 at The Westin Hotel in Pasadena, California.

City of Hope study finds diabetes A1c test misses most cases

March 28, 2019 | City of Hope

The hemoglobin A1c blood test is widely used to diagnose type 1 and type 2 diabetes but it is actually unable to detect the disease in most patients, according to a new study presented March 23 at the Endocrine Society’s annual meeting.

Study by diabetes expert describes promising type 1 treatments

February 14, 2019 | Katie Neith

A paper co-authored by Bart Roep, Ph.D., Chan Soon-Shiong Shapiro Distinguished Chair in Diabetes and the founding chair of the Department of Diabetes Immunology at City of Hope, published in Nature explores new ways of replacing beta cells after too many of them have been killed by the immune system.

Landmark human insulin study marks 40-year anniversary

January 29, 2019 | Michael Easterling

In January 1979, the National Academy of Sciences published a paper about an innovative discovery at City of Hope that would forever change how diabetes is treated. Arthur Riggs, Ph.D., and Keiichi Itakura, Ph.D., revolutionized diabetes treatment when they made a novel gene, one that coded for human insulin.

Islet cell transplant helps diabetes patient put three decades of complications behind him

December 20, 2018 | Zen Vuong

Meet City of Hope Rose Parade float rider Roger Sparks, a successful entrepreneur who spent more than half his life battling type 1 diabetes. On Jan. 1, Sparks will celebrate exactly three years of living without any diabetes-related complications, thanks to leading-edge treatment he received at City of Hope.

For this diabetes researcher, the mission is personal

December 5, 2018 | City of Hope

Sampath Rangasamy, Ph.D., a researcher at City of Hope affiliate TGen, has spent his whole life researching type 1 diabetes, a personal battle since he himself suffers from the disease.

Researchers identify new target for potential type 1 diabetes treatment

October 18, 2018 | Katie Neith

Recently a team of researchers led by City of Hope scientists identified a new potential target to keep the immune system stable and islet beta cells healthy, in an effort to keep type 1 diabetes at bay.

Core Connection: Comprehensive Metabolic Phenotyping Core

October 4, 2018 | Katie Neith

As both genetics and environmental stimuli can have an effect on the progression of illnesses and on the efficacy of treatments, one particularly important area of study is metabolism, which lies at the intersection of many diseases.

The Wanek Family Project to Cure Type 1 Diabetes: 18 months later

August 9, 2018 | Dory Benford

Last year, the City of Hope Wanek Family Project to Cure Type 1 Diabetes launched 16 projects across multiple disciplines, including immunology, endocrinology, cellular therapeutics, nutrition and metabolism. Now, 18 months in, we are pleased with our progress and more optimistic than ever about finding a cure.